Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Net Cash Flow (2017 - 2025)

Purple Biotech has reported Net Cash Flow over the past 6 years, most recently at $3.9 million for Q4 2022.

  • Quarterly Net Cash Flow rose 94.19% to $3.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2022, up 10370.73% year-over-year, with the annual reading at $1.3 million for FY2025, 118.48% up from the prior year.
  • Net Cash Flow was $3.9 million for Q4 2022 at Purple Biotech, up from -$2.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $12.7 million in Q1 2022 and troughed at -$51.1 million in Q4 2020.
  • The 5-year median for Net Cash Flow is -$74000.0 (2018), against an average of -$4.1 million.
  • Year-over-year, Net Cash Flow soared 2291.89% in 2019 and then plummeted 3250.31% in 2020.
  • A 5-year view of Net Cash Flow shows it stood at -$74000.0 in 2018, then soared by 2291.89% to $1.6 million in 2019, then plummeted by 3250.31% to -$51.1 million in 2020, then surged by 103.9% to $2.0 million in 2021, then skyrocketed by 94.19% to $3.9 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Net Cash Flow are $3.9 million (Q4 2022), -$2.9 million (Q3 2022), and -$9.4 million (Q2 2022).